Nucleic acids, polypeptides, and methods for modulating apoptosis

Details for Australian Patent Application No. 2002324519 (hide)

Owner Senesco, Inc.

Inventors Petrov, Larry; Wang, Tzann-Wei; Cliche, Dominic; Carlson, John C.; Thompson, John E.; Narayansingh, Richard; Kaup, Marianne; Taylor, Catherine

Agent Shelston IP

Pub. Number AU-B-2002324519

PCT Number PCT/US02/23254

PCT Pub. Number WO2003/010286

Priority 10/141,647 07.05.02 US; 09/909,796 23.07.01 US

Filing date 23 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 15 May 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 10/141,647 07.05.02 US; 09/909,796 23.07.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002324519

15 February 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Sep 2005

15 May 2008 Application Accepted

  Published as AU-B-2002324519

13 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002324520-ALGAAS OR INGAP LOW TURN-ON VOLTAGE GAAS-BASED HETEROJUNCTION BIPOLAR TRANSISTOR

2002324518-IMPROVED POWERED GAIT ORTHOSIS AND METHOD OF UTILIZING SAME